Literature DB >> 7612075

Regulation of pituitary vasopressin receptors during chronic stress: relationship to corticotroph responsiveness.

G Aguilera1, Q Pham, C Rabadan-Diehl.   

Abstract

The relationship between vasopressin (VP) receptor levels in the anterior pituitary and VP-stimulated ACTH release in vitro was studied in rats subjected to various chronic stress paradigms. The stress models used were water deprivation for 60 h and administration of 2% NaCl in the drinking water (both of which are associated with decreased pituitary ACTH responsiveness), and repeated i.p. hypertonic saline injections or repeated daily immobilization for 14 days (associated with increased ACTH responsiveness to novel stimuli). VP receptors were measured by binding of [3H]arginine-VP to anterior pituitary membrane-rich fractions, and ACTH responses to VP in collagenase dispersed anterior pituitary cells. In control rats, binding of [3H]AVP was saturable and high affinity, with a Kd of 0.45 +/- 0.05 nM and a Bmax of 138.8 +/- 8.1 fmol/mg. In pituitary membranes from stressed rats, binding affinity was unchanged, but Bmax changed according to the type of stress. While VP binding was markedly reduced after water deprivation and 2% saline (25% and 49%, respectively), it was significantly increased after repeated i.p. hypertonic saline injections and repeated immobilization (126% and 154% of controls, respectively). The changes in VP binding were associated to parallel changes in maximum VP-stimulated ACTH production in vitro, with a 34% decrease in water deprived rats and a 25% increase in hypertonic saline injected rats. The potentiating effect of VP on corticotropin releasing hormone-stimulated ACTH was also reduced in cells from water-restricted rats, and increased in cells from rats given repeated injections of hypertonic saline. The data show a direct relationship between changes in corticotroph responsiveness and changes in pituitary VP receptors during chronic stress, suggesting that pituitary VP receptor regulation is involved in the adaptation of the HPA axis during chronic stress.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7612075     DOI: 10.1111/j.1365-2826.1994.tb00586.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  10 in total

1.  Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates.

Authors:  Alberto Galbusera; Alessia De Felice; Stefano Girardi; Giacomo Bassetto; Marta Maschietto; Katsuhiko Nishimori; Bice Chini; Francesco Papaleo; Stefano Vassanelli; Alessandro Gozzi
Journal:  Neuropsychopharmacology       Date:  2016-12-20       Impact factor: 7.853

2.  Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis.

Authors:  H S Chowdrey; P J Larsen; M S Harbuz; D S Jessop; G Aguilera; D J Eckland; S L Lightman
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

Review 3.  Stress, sex, and addiction: potential roles of corticotropin-releasing factor, oxytocin, and arginine-vasopressin.

Authors:  Verónica Bisagno; Jean Lud Cadet
Journal:  Behav Pharmacol       Date:  2014-09       Impact factor: 2.293

Review 4.  The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress.

Authors:  Greti Aguilera; Sivan Subburaju; Sharla Young; Jun Chen
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

Review 5.  Vasopressin: behavioral roles of an "original" neuropeptide.

Authors:  Heather K Caldwell; Heon-Jin Lee; Abbe H Macbeth; W Scott Young
Journal:  Prog Neurobiol       Date:  2007-11-04       Impact factor: 11.685

6.  Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors.

Authors:  Sharla F Young; Cristiana Griffante; Greti Aguilera
Journal:  Cell Mol Neurobiol       Date:  2007-02-21       Impact factor: 4.231

7.  Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice.

Authors:  Devon Collins; Matthew Randesi; Joel Correa da Rosa; Yong Zhang; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2018-07-19       Impact factor: 4.530

Review 8.  Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists.

Authors:  Valeska Cid-Jofré; Macarena Moreno; Miguel Reyes-Parada; Georgina M Renard
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

9.  Stress responsiveness of the hypothalamic-pituitary-adrenal axis: age-related features of the vasopressinergic regulation.

Authors:  Nadezhda D Goncharova
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-12       Impact factor: 5.555

10.  Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia.

Authors:  Derya Guzel; Ahmet Bulent Yazici; Tugba Mutu Pek; Songul Doganay; Alime Burcin Saykan Simsek; Kadir Saglam; Caglar Turan; Esra Yazici
Journal:  Neuropsychiatr Dis Treat       Date:  2018-07-16       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.